Merck Animal Health and Kansas Gov. Laura Kelly jointly announced the US$895 million expansion of Merck Animal Health’s manufacturing facility in De Soto, Kansas.
The expansion will be constructed on an existing Merck-owned property that is the site of its biologics facility. It includes an US$860 million investment in the site’s existing manufacturing facility and a further US$35 million investment in its research and development laboratories.
The 200,000-square-foot manufacturing facility project will expand filling and freeze dryer capacity for large molecule vaccines and biologic products for Merck Animal Health. As a Center of Excellence, it will play a pivotal role in the manufacturing of Merck Animal Health’s products and will complement Merck Animal Health’s extensive U.S. and international network of animal health product manufacturing plants.
Site preparation and facility design will start immediately, creating 2,500 construction jobs. Commercial manufacturing is expected to begin in 2030, creating more than 200 full-time roles.
Merck Animal Health’s significant investment in its research and development laboratories will enhance its research capabilities, focusing on advancing Merck Animal Health’s global drug discovery and development initiatives. The investment will continue to drive Merck Animal Health’s innovative research and development of novel parasiticides and therapeutics, reinforcing the company’s dedication to improving animal health and welfare worldwide.
“Our De Soto, Kansas, manufacturing facility is strategically located in the heart of the Animal Health Corridor. This region is renowned for its concentration of animal health companies, fostering an unparalleled ecosystem for innovation, collaboration and industry leadership,” said Richard DeLuca, president, Merck Animal Health. “This investment in our site is designed to increase Merck Animal Health’s ability to meet the growing customer demand for its portfolio of animal biologics products and ensure the company remains at the forefront of innovation in the animal health sector. This initiative also reflects our dedication to advancing animal health and our on-going investment in the communities where we operate.”
Merck Animal Health is partnering with the state of Kansas on expansion of the existing manufacturing facility. The investment demonstrates Merck Animal Health’s commitment to the U.S. market, in which the company has significantly invested to deliver innovative health solutions that advance the prevention and treatment of animal diseases. This marks one of the largest economic development projects in Kansas’ recent history and the largest for Merck Animal Health.
